PAPER Ono M, Ito T, Yamaki S, Hori Y, Zhou Q, Zhao X, Muramoto S, Yamamoto R, Furuyama T, Sakata-Haga H, Hatta T, Hamaguchi T, Kato N
SEARCH RESULTS
330733 RESULTS
PAPER Liu S, Chen H, He XD, Yang XO
Glucometabolic-Related Genes as Diagnostic Biomarkers and Therapeutic Targets for Alzheimer's Disease and Type 2 Diabetes Mellitus: A Bioinformatics Analysis.
Neurol Res Int. 2024;2024:5200222. Epub 2024 Apr 2 PubMed: 38595695PAPER
Corrigendum: Genistein protects hippocampal neurons against injury by regulating calcium/calmodulin dependent protein kinase IV protein levels in Alzheimer's disease model rats.
Neural Regen Res. 2024 Dec 1;19(12):2660. Epub 2024 Apr 8 PubMed: 38595284PAPER Abdullahi A, Wong TW, Ng SS
Effects of home-based and telerehabilitation exercise on mental and physical health, and disease cost in people with Alzheimer's disease: A meta-analysis.
Ageing Res Rev. 2024 Apr 9;97:102284. PubMed: 38599523PAPER Dou J, Zhang X, Hu C, Gao Y, Zhao Y, Hei M, Wang Z, Guo N, Zhu H
QKL injection ameliorates Alzheimer's disease-like pathology by regulating expression of RAGE.
Exp Gerontol. 2024 Apr 12;190:112422. PubMed: 38599502PAPER Liew TM, Ang LC
Examining the non-linear effects of education on Alzheimer's and non-Alzheimer's disease: Sex-stratified analysis of 17,671 older persons.
Soc Sci Med. 2024 Apr 4;348:116845. PubMed: 38598986PAPER Liu Y, Yan D, Yang L, Chen X, Hu C, Chen M
Stathmin 2 is a potential treatment target for TDP-43 proteinopathy in amyotrophic lateral sclerosis.
Transl Neurodegener. 2024 Apr 11;13(1):20. PubMed: 38600555PAPER Cuní-López C, Stewart R, E Oikari L, Hong Nguyen T, L Roberts T, Sun Y, C Guo C, K Lupton M, R White A, Quek H
Correction: Advanced patient-specific microglia cell models for pre-clinical studies in Alzheimer's disease.
J Neuroinflammation. 2024 Apr 10;21(1):90. PubMed: 38600570PAPER Adler CH, Halverson M, Zhang N, Shill HA, Driver-Dunckley E, Mehta SH, Atri A, Caviness JN, Serrano GE, Shprecher DR, Belden CM, Sabbagh MN, Long K, Beach TG
Conjugal Synucleinopathies: A Clinicopathologic Study.
Mov Disord. 2024 Apr 10; PubMed: 38597193PAPER Sini P, Galleri G, Ciampelli C, Galioto M, Padedda BM, Lugliè A, Iaccarino C, Crosio C
Evaluation of cyanotoxin L-BMAA effect on α-synuclein and TDP43 proteinopathy.
Front Immunol. 2024;15:1360068. Epub 2024 Mar 26 PubMed: 38596666PAPER Yu J, Zhao Z, Li Y, Chen J, Huang N, Luo Y
Role of NLRP3 in Parkinson's disease: Specific activation especially in dopaminergic neurons.
Heliyon. 2024 Apr 15;10(7):e28838. Epub 2024 Mar 28 PubMed: 38596076PAPER Ng XY, Cao M
Dysfunction of synaptic endocytic trafficking in Parkinson's disease.
Neural Regen Res. 2024 Dec 1;19(12):2649-2660. Epub 2024 Mar 1 PubMed: 38595283PAPER De Bartolo MI, Belvisi D, Mancinelli R, Costanzo M, Caturano C, Leodori G, Berardelli A, Fabbrini G, Vivacqua G
A systematic review of salivary biomarkers in Parkinson's disease.
Neural Regen Res. 2024 Dec 1;19(12):2613-2625. Epub 2024 Mar 1 PubMed: 38595280PAPER Lange-Maia BS, Wagner M, Rogers CA, Mehta RI, Bennett DA, Tangney C, Schoeny ME, Halloway S, Arvanitakis Z
Profiles of Lifestyle Health Behaviors and Postmortem Dementia-Related Neuropathology.
J Gerontol A Biol Sci Med Sci. 2024 Apr 10; PubMed: 38597160PAPER Fandler-Höfler S, Storti B
Acquired cerebral amyloid angiopathy: more questions than answers.
Eur J Neurol. 2024 Apr 10;:e16299. PubMed: 38597136Current Filters
- Date Range : All x